US Backs Intellectual Property Waiver On COVID-19 Vaccines
Updated: May 7, 2021
The Biden administration is supporting an easing of patent protections on COVID-19 vaccines to help poorer countries produce more doses and, hopefully, end the pandemic more quickly.
The idea, proposed by India and South Africa, would waive intellectual property protections on COVID-19 vaccines.
Pharmaceutical companies are upset with the move as the US has historically opposed infringing on IP protections.
The European Union will now consider the proposal. Under the rules of the World Trade Organization, the decision must be passed by unanimous consent.
Photo Source: spencerbdavis